SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
{4} To Conduct Phase II Clinical Trial In Europe With TB4 For Venous Stasis Ulcers; Pharmaceutical Firm Accelerates Phase II Commitment